SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-001424
Filing Date
2023-03-10
Accepted
2023-03-10 17:10:27
Documents
12
Period of Report
2023-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio_8k.htm   iXBRL 8-K 25318
  Complete submission text file 0001683168-23-001424.txt   197856

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phio-20230310.xsd EX-101.SCH 3233
3 XBRL LABEL FILE phio-20230310_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE phio-20230310_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT phio_8k_htm.xml XML 3614
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 23724652
SIC: 2834 Pharmaceutical Preparations